Part 1: Comprehensive lipid-lowering update: How to get your high-risk patients to the new NCEP goalsNow that the optimal LDL-cholesterol level for patients with coronary heart disease or its risk equivalents is substantially below 100 mg/dL, consider aggressive lipid-lowering strategies in this group. With the advent of more powerful statins, combination therapy, and newer nonstatin agents, you can help a significantly greater proportion of your patients attain their lipid goals.
ReadMORE
ARTICLESRetrospective analysis demontrates that switching statins hinders treatment compliance, persistence Read
Early invasive stategy no better than selectively invasive approach for acute coronary syndromes Read
Making the most of cardiac rehabilitation Read
Diuretics: Still first-line therapy for
hypertension? Read